logo

Spectrum Pharmaceuticals Inc (SPPI)



Trade SPPI now with
  Date
  Headline
11/13/2018 7:03:00 AM Spectrum Appoints Jeffrey Vacirca To Its Board
10/23/2018 7:05:36 AM Spectrum Pharma Gets FDA Approval Of KHAPZORY For Injection
10/18/2018 7:04:04 AM Spectrum Pharmaceuticals Appoints Francois Lebel As Chief Medical Officer
9/12/2018 7:07:55 AM Spectrum Expands Poziotinib Clinical Trial Into First-Line Therapy And Doses First Patient
6/29/2018 7:08:55 AM Spectrum Pharma Presents ADVANCE Phase 3 ROLONTIS (eflapegrastim) Data At MASCC 2018
5/3/2018 7:23:46 AM Spectrum Pharma Announces Licensing Agreement On Certain Methods Of Use Of Poziotinib
5/1/2018 7:07:50 AM Spectrum Enters Next-Generation Sequencing Companion Diagnostic Partnership With Thermo Fisher Scientific
4/10/2018 5:02:32 AM Spectrum Pharma Says Update Of MD Anderson’s Phase 2 Data Studying Poziotinib In EGFR Exon 20 Mutant NSCLC Patients
3/6/2018 4:02:12 PM Spectrum Pharma Q4 Loss/share $0.29 Vs. Loss $0.23 Year Ago
2/27/2018 6:06:17 AM Spectrum Pharma Names William Ashton To Its Board
2/5/2018 7:06:44 AM Spectrum Pharma: ROLONTIS (eflapegrastim) Met Primary Endpoint In Phase 3 ADVANCE Study